Yahoo Web Search

Search results

1. ltd.aruplab.com › Tests › PubSARS-CoV-2 (COVID-19) by NAA | ARUP Laboratories Test Directory

   ltd.aruplab.com › Tests › Pub

   • Cached

   The Coronavirus SARS-CoV-2 (COVID-19) by nucleic acid amplification test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for U.S. laboratories certified under CLIA to perform high complexity tests. This test has not been FDA cleared or approved.

2. www.labcorp.com › tests › 139900139900: 2019 Novel Coronavirus (COVID-19), NAA | Labcorp

   www.labcorp.com › tests › 139900

   • Cached

   Details. LOINC®. Back to Top. 2019 Novel Coronavirus (COVID-19), NAA. TEST: 139900. CPT: 87635. Print Share Include LOINC® in print. Synonyms. 2019 Novel Coronavirus. COVID-19. SARS-CoV-2. Special Instructions. Please note: Labcorp does not currently collect specimens for this test.

3. www.cdc.gov › coronavirus › 2019-ncovNucleic Acid Amplification Tests (NAATs) | CDC

   www.cdc.gov › coronavirus › 2019-ncov

   • Cached

   May 12, 2023 · Amplifying those nucleic acids enables NAATs to detect very small amounts of SARS-CoV-2 RNA in a specimen, making these tests highly sensitive for diagnosing COVID-19. In other words, NAATs can reliably detect small amounts of SARS-CoV-2 and are unlikely to return a false-negative result of SARS-CoV-2.

4. www.cdc.gov › coronavirus › 2019-ncovOverview of Testing for SARS-CoV-2, the virus that causes ...

   www.cdc.gov › coronavirus › 2019-ncov

   • Cached

   • Examples of Screening Testing Include
   • How to Conduct Screening Testing
   • Settings to Prioritize For Screening Testing

   Point-in-time screening testing

   Serial screening testing

   See full list on cdc.gov

   When screening testingis used, it should be applied to participants regardless of vaccination status. Any type of viral testcan be used for screening purposes; however, consider the characteristics (including accessibility, accuracy and efficiency) of different test types to determine which best suits screening testing needs. People without symptom...

   See full list on cdc.gov

   Settings that should be prioritized for screening testinginclude facilities and situations where transmission risk is high and the population served is at high risk of severe outcomes from COVID-19 or there is limited access to healthcare, including: 1. Specific settings that have demonstrated high potential for rapid and widespread virus spread to...

   See full list on cdc.gov

5. www.covid19treatmentguidelines.nih.gov › overviewSARS-CoV-2 Testing | COVID-19 Treatment Guidelines

   www.covid19treatmentguidelines.nih.gov › overview

   • Cached

   Dec 20, 2023 · For diagnosing current SARS-CoV-2 infection, the CDC recommends using a specimen from the upper respiratory tract (e.g., nasal, nasopharyngeal). 5 Testing lower respiratory tract specimens is also an option in certain circumstances (e.g., in those receiving mechanical ventilation).

6. www.aafp.org › pubs › afpInterpreting SARS-CoV-2 Diagnostic Tests: Common ... - AAFP

   www.aafp.org › pubs › afp

   • Cached

   Apr 15, 2021 · SARS-CoV-2 is the novel coronavirus that causes COVID-19. The spectrum of asymptomatic, presymptomatic, and symptomatic SARS-CoV-2 transmission presents challenges for evaluating...

7. health.clevelandclinic.org › different-types-ofUnderstanding the Different Types of COVID-19 Tests

   health.clevelandclinic.org › different-types-of

   • Cached

   Sep 14, 2021 · There are currently two primary types of COVID-19 tests being used to test patients for COVID-19: molecular tests (also known as nucleic acid, RNA or PCR tests) and rapid antigen tests. The third type of testing looks for antibodies created to combat the virus. While sometimes used, these tests can only identify if you had the virus in the past.